Siponimod

3 trials 2 recruiting LOncology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

2 Countries

Phase II

Phase IV

Phase II: 1 Phase IV: 2

Indications tested

Progressive multiple sclerosis 3 Multiple sclerosis 1 Secondary progressive multiple sclerosis 1 Primary progressive multiple sclerosis 1

Sponsors using this IMP

Azienda Ospedaliera Universitaria Integrata Verona 2 Antwerp University Hospital 1

All trials

3 total

Exploring the effect of a novel therapy on chronic intrathecal inflammation in patients with active progressive multiple sclerosis Recruiting

2024-512283-65-00 Phase IV 1 country Azienda Ospedaliera Universitaria Integrata Verona
Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis Recruiting

2024-518374-13-00 Phase IV 1 country Azienda Ospedaliera Universitaria Integrata Verona
Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placeb… Ended

2023-503190-38-00 Phase II 1 country Antwerp University Hospital

Showing 1–3 of 3 trials

← All drugs A–Z